Ranitidine Market Worth US$ 387.1 Million by 2027 – COVID-19 Impact and Global Analysis by The Market Reports

The global Ranitidine market was valued at US$ 347.8 million in 2020 and is expected to reach US$ 387.1 million by the end of 2027, growing at a CAGR of 1.6% during 2021-2027.

Ranitidine is a histamine H2 antagonists and available as both over-the-counter (OTC) and prescription drug, indicated in the treatment of gastroesophageal reflux disease (GERD). Ranitidine decreases the acid production from stomach for up to 12 hours. Also, ranitidine is commonly used in erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome. It could be taken orally or intravenously.

Global Ranitidine Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Ranitidine Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.

Key Companies profiled in this report are GSK, Merck, Boehringer Ingelheim, Strides Pharma Science Limited (Strides Shasun), Sun Pharma, Tocris Bioscience (R & D Systems) and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.

Find more details at: https://www.themarketreports.com/report/global-ranitidine-market-outlook

Segment by Type

  • Tablet
  • Syrup
  • Injection

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Table of Content:

1 Ranitidine Market Overview

2 Ranitidine Market Competition by Manufacturers

3 Ranitidine Retrospective Market Scenario by Region

4 Global Ranitidine Historic Market Analysis by Type

5 Global Ranitidine Historic Market Analysis by Application

6 Key Companies Profiled

7 Ranitidine Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Ranitidine Market Dynamics

10 Global Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Media Contact

Company Name: The Market Reports

Contact Person: Shirish Gupta

Email: sales@themarketreports.com

Phone: +1-631-407-1315

Leave a Reply

Your email address will not be published. Required fields are marked *